[1]王凯 顾嘉钦 朱珺 侯旭敏.精细化管理促进辅助药物合理使用[J].中国卫生质量管理,2019,26(03):054-57.[doi:10.13912/j.cnki.chqm.2019.26.3.16]
点击复制

精细化管理促进辅助药物合理使用
分享到：

《中国卫生质量管理》[ISSN:1006-7515/CN:CN 61-1283/R]

卷:
第26卷
期数:
2019年03期
页码:
054-57
栏目:
医疗质量
出版日期:
2019-05-28

文章信息/Info

作者:
王凯 顾嘉钦 朱珺 侯旭敏
上海市胸科医院
关键词:
辅助药物; 合理用药; 管理对策; 信息化手段
Keywords:
Auxiliary Drugs;  Rational Medication;  Management Strategy;  Information Means
DOI:
10.13912/j.cnki.chqm.2019.26.3.16
摘要:
辅助药物已成为推动我国药品费用快速增长的主要因素之一，也是不合理用药问题的多发区。为不断提升合理用药水平，针对辅助药物实施专项管控，探索出一条具有专科特色的管理模式，主要做法有：成立专项管控小组，形成院、科、组、人的多维管理模式；制订辅助药物目录，设定科室管控标准；确定辅助药物考核流程，临床药师进行处方点评；实行诫勉谈话制度，落实考核方案；借助信息化平台实现辅助药物管理。实施后，患者均次住院辅助药费用较全面管控前下降44.6%，不合理住院处方比例由管控前的27.30%下降至2.56%。加强对辅助药物的管理对提高医院合理用药水平，规范医生用药行为及减轻患者就医负担具有重要意义。
Abstract:
Auxiliary drugs have become one of the main factors driving the rapid growth of pharmacy cost in China, which was also a frequent area for irrational medication. In order to continuously improve the rational medication, special control over auxiliary drugs was implemented, and a management model with special characteristics was explored. The main measures included: setting up a special management and control group to form a multi-dimensional management mode of hospital, departments, groups and people; developing an auxiliary drug directory; setting up the department control standard; identifying the auxiliary drug assessment process; clinical pharmacist prescription assessment; implementing the system of sermon conversation, implementing the evaluation plan, and implementing the auxiliary drug management through the information platform. After the full implementation, the patient's hospital auxiliary drug fee was reduced by 44.62%, and the proportion of irrational medication prescription was reduced from 27.30% to 2.56%. It was of great significance to strengthen the management of auxiliary drugs to improve the level of reasonable medication in hospitals, to regulate the behavior of doctors and to reduce the medical burden of patients.

参考文献/References:

［1］王静, 郭宇姝, 游亮,等. 某院住院药房辅助用药使用情况分析［J］.解放军药学学报, 2017，33(5):467-468.

相似文献/References:

[1]赵娴 张青 鹿秀丽 王雨来.基于HIMSS EMRAM 7 标准的合理用药系统建立与应用[J].中国卫生质量管理,2019,26(03):090.[doi:10.13912/j.cnki.chqm.2019.26.3.25]
[2]王栋罗平刘韶尹桃龚志成.住院患者静脉输液专项管理实践[J].中国卫生质量管理,2022,29(05):034.[doi:10.13912/j.cnki.chqm.2022.29.5.09 ]
　WANG Dong,LUO Ping,LIU Shao.Special Management Practice of Intravenous Infusion for Inpatients[J].Chinese Health Quality Management,2022,29(03):034.[doi:10.13912/j.cnki.chqm.2022.29.5.09 ]
[3]邓明林伟龙时黎明杨谨成安宇杨娟周成诚杨文静.北京市79家医院抗肿瘤药物规范使用现状与影响因素分析[J].中国卫生质量管理,2022,29(11):021.[doi:10.13912/j.cnki.chqm.2022.29.11.06 ]
　DENG Ming,LIN Weilong,SHI Liming.Current Status and Influencing Factors of Standardized Use of Antitumor Drugs in 79 Hospitals in Beijing[J].Chinese Health Quality Management,2022,29(03):021.[doi:10.13912/j.cnki.chqm.2022.29.11.06 ]
[4]郑婷婷李锦卞婧张威甄健存.以合理用药绩效管理促进医院高质量发展[J].中国卫生质量管理,2022,29(12):047.[doi:10.13912/j.cnki.chqm.2022.29.12.11 ]
　ZHENG Tingting,LI Jin,BIAN Jing.To Promote the High Quality Development of Hospitals by Performance Management of Rational Drug Use[J].Chinese Health Quality Management,2022,29(03):047.[doi:10.13912/j.cnki.chqm.2022.29.12.11 ]
[5]府裕琦 吕娟丽 陈熙 吕红梅 杨小强 赵颖波.基于全国抗菌药物临床应用监测网的手术组病例用药合理性分析[J].中国卫生质量管理,2024,31(04):001.[doi:10.13912/j.cnki.chqm.2024.31.4.01]
　FU Yuqi,LV Juanli,CHEN Xi,et al.Analysis of the Rationality of Drug Use in the Surgical Group Based on the Center for Antibacterial Surveillance[J].Chinese Health Quality Management,2024,31(03):001.[doi:10.13912/j.cnki.chqm.2024.31.4.01]
[6]陈熙 府裕琦 吕红梅 赵颖波.我国医疗机构患者自备输注药品管理现状调查分析[J].中国卫生质量管理,2024,31(04):011.[doi:10.13912/j.cnki.chqm.2024.31.4.03 ]
　CHEN Xi,FU Yuqi,LV Hongmei,et al.Investigation and Analysis of Management Status about Patient Self-Provided Infusion Drugs in Medical Institutions in China[J].Chinese Health Quality Management,2024,31(03):011.[doi:10.13912/j.cnki.chqm.2024.31.4.03 ]

更新日期/Last Update: 2019-05-28